International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
Gram-Positive Infections: From Clinical Burden to Innovative Treatment Strategies
| Author(s) | Dr. Khushbu Gautam |
|---|---|
| Country | India |
| Abstract | Abstract Serious infections caused by Gram-positive bacteria remain a major public health challenge globally due to the increasing prevalence of antimicrobial resistance. Pathogens such as Staphylococcus aureus, Enterococcus spp., and Streptococcus pneumoniae are responsible for a wide range of life-threatening infections including pneumonia, meningitis, bacteremia, endocarditis, osteomyelitis, and device-associated infections. The emergence of multidrug-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), vancomycin-intermediate S. aureus (VISA), and vancomycin-resistant S. aureus (VRSA) has significantly limited therapeutic options and increased healthcare costs and mortality. In addition, resistance to newer antimicrobial agents including linezolid and quinupristin-dalfopristin has also been reported. This review examines the epidemiology, resistance mechanisms, clinical impact, and treatment challenges associated with Gram-positive infections. Strategies for prevention and control including antimicrobial stewardship, infection prevention practices, vaccination, and development of novel antibiotics are discussed. Addressing the growing burden of Gram-positive infections requires integrated global efforts combining clinical management with innovative drug discovery. |
| Keywords | Keywords: Gram-positive infections, MRSA, VRE, antimicrobial resistance, Staphylococcus aureus, antibiotic resistance |
| Field | Biology > Bio + Chemistry |
| Published In | Volume 8, Issue 2, March-April 2026 |
| Published On | 2026-04-12 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals